Last updated 33 days ago
A Clinical Study of MK-6194 for the Treatment of Vitiligo (MK-6194-007)
165 patients around the world
Available in Spain, Chile, United States
Merck Sharp & Dohme LLC
3Research sites
165Patients around the world
This study is for people with
Vitiligo
Generalized vitiligo
Requirements for the patient
To 75 Years
All Gender
Medical requirements
Sites
Bulnes 1937, CABA, Buenos Aireswww.psoriahue.com/
Av. Manquehue Norte 2051 C, Vitacura, Metropolitana, 7640881dermacross.cl
SponsorMerck Sharp & Dohme LLC
Conditions
Generalized vitiligo
Requirements
To 75 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT06113328
